Tao Fu
Patrimonio netto: 5 $ in data 30/06/2026
Patrimonio netto: 5 $ in data 30/06/2026
Attualmente, Tao Fu ricopre la posizione di presidente, direttore operativo e direttore di Zai Lab Ltd. Nella sua carriera passata il signor Fu ha ricoperto la posizione di Manager-Business Development presso Becton, Dickinson & Co., Vice Presidente per Bristol Myers Squibb Co., Vice Presidente-Planning & Development presso Scios, Inc., Vice Presidente-Business Development per Janssen Pharmaceuticals, Inc. e Chief Commercial & Business Officer, Executive VP presso Portola Pharmaceuticals, Inc. Il signor Fu ha conseguito una laurea presso l'Università di Rochester, un MBA presso la Vanderbilt University e una laurea presso la Tsinghua University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/08/2026 | 548.558 ( 1,27% ) | 5 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ATTOVIA THERAPEUTICS, INC. | Fondatore | 16/12/2022 |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Investitore di Private Equity | 01/05/2022 |
| Società | Posizione | Fine |
|---|---|---|
| ZAI LAB LIMITED | Presidente | - |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 21/09/2018 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Corporate Officer/Principal | 01/01/2006 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/01/2000 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Becton, Dickinson & Co.
Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zai Lab Ltd.
Zai Lab Ltd. BiotechnologyHealth Technology Develops medicine for cancer, autoimmune and infectious diseases | Health Technology |
Attovia Therapeutics
Attovia Therapeutics BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that researches & develops therapeutic products in the fields of immune-mediated diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale